Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Potential predictors of disease progression for main-duct intraductal papillary mucinous neoplasms of the pancreas.

Ogura T, Masuda D, Kurisu Y, Edogawa S, Imoto A, Hayashi M, Uchiyama K, Higuchi K.

J Gastroenterol Hepatol. 2013 Nov;28(11):1782-6. doi: 10.1111/jgh.12301.

PMID:
23800049
2.

Management of intraductal papillary mucinous neoplasm of the pancreas.

Sugiyama M, Suzuki Y, Abe N, Mori T, Atomi Y.

J Gastroenterol. 2008;43(3):181-5. doi: 10.1007/s00535-008-2159-8. Epub 2008 Mar 29. Review.

PMID:
18373159
3.

[Intraductal papillary mucinous neoplasm of the pancreas, IPMN].

Sirén J.

Duodecim. 2013;129(6):591-8. Review. Finnish.

PMID:
23614224
4.

Imaging IPMN: take home messages and news.

Vullierme MP, d'Assignies G, Ruszniewski P, Vilgrain V.

Clin Res Hepatol Gastroenterol. 2011 Jun;35(6-7):426-9. doi: 10.1016/j.clinre.2011.02.011. Epub 2011 May 25. Review.

PMID:
21616741
5.

Intraductal papillary mucinous neoplasm--when to resect?

Waters JA, Schmidt CM.

Adv Surg. 2008;42:87-108. Review.

PMID:
18953811
6.

Surgical management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas.

Farnell MB.

J Gastrointest Surg. 2008 Mar;12(3):414-6. Epub 2007 Oct 30. Review.

PMID:
17968632
7.

[Surgical management of intraductal papillary mucinous neoplasms].

Jang JY.

Korean J Gastroenterol. 2008 Oct;52(4):220-5. Review. Korean.

8.

Malignant potential of intraductal papillary mucinous neoplasms of the pancreas.

Nakajima Y, Yamada T, Sho M.

Surg Today. 2010 Sep;40(9):816-24. doi: 10.1007/s00595-009-4227-y. Epub 2010 Aug 26. Review.

PMID:
20740343
9.

Intraductal papillary mucinous neoplasm: a clinicopathologic review.

Augustin T, Vandermeer TJ.

Surg Clin North Am. 2010 Apr;90(2):377-98. doi: 10.1016/j.suc.2009.12.008. Review.

PMID:
20362793
10.

[Differentiated therapy for intraductal papillary mucinous neoplasms].

Wente MN, Schmied BM, Schmidt J, Büchler MW.

Chirurg. 2009 Jan;80(1):7-13. doi: 10.1007/s00104-008-1579-6. Review. German.

PMID:
19082569
11.

Systematic review and meta-analysis comparing the surgical outcomes of invasive intraductal papillary mucinous neoplasms and conventional pancreatic ductal adenocarcinoma.

Koh YX, Chok AY, Zheng HL, Tan CS, Goh BK.

Ann Surg Oncol. 2014 Aug;21(8):2782-800. doi: 10.1245/s10434-014-3639-0. Epub 2014 Apr 1. Review.

PMID:
24687151
12.

Systematic review and meta-analysis of the spectrum and outcomes of different histologic subtypes of noninvasive and invasive intraductal papillary mucinous neoplasms.

Koh YX, Zheng HL, Chok AY, Tan CS, Wyone W, Lim TK, Tan DM, Goh BK.

Surgery. 2015 Mar;157(3):496-509. doi: 10.1016/j.surg.2014.08.098. Epub 2015 Feb 3. Review.

PMID:
25656693
13.

Evaluation of the Fukuoka Consensus Guidelines for intraductal papillary mucinous neoplasms of the pancreas: Results from a systematic review of 1,382 surgically resected patients.

Goh BK, Lin Z, Tan DM, Thng CH, Khor CJ, Lim TK, Ooi LL, Chung AY.

Surgery. 2015 Nov;158(5):1192-202. doi: 10.1016/j.surg.2015.03.021. Epub 2015 May 29. Review.

PMID:
26032832
14.

Diagnostic yield of endoscopic retrograde cholangiopancreatography-based cytology for distinguishing malignant and benign intraductal papillary mucinous neoplasm: systematic review and meta-analysis.

Suzuki R, Thosani N, Annangi S, Komarraju A, Irisawa A, Ohira H, Obara K, Fleming JB, Guha S, Bhutani MS.

Dig Endosc. 2014 Jul;26(4):586-93. doi: 10.1111/den.12230. Epub 2014 Jan 22. Review.

PMID:
24450356
15.

Intraductal papillary mucinous neoplasms.

Sahora K, Fernández-del Castillo C.

Curr Opin Gastroenterol. 2015 Sep;31(5):424-9. doi: 10.1097/MOG.0000000000000198. Review.

PMID:
26125316
16.

Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter?

Nehra D, Oyarvide VM, Mino-Kenudson M, Thayer SP, Ferrone CR, Wargo JA, Muzikansky A, Finkelstein D, Warshaw AL, Castillo CF.

Pancreatology. 2012 Jul-Aug;12(4):358-63. doi: 10.1016/j.pan.2012.05.011. Epub 2012 Jun 15. Review.

17.

The Sendai and Fukuoka consensus criteria for the management of branch duct IPMN - A meta-analysis on their accuracy.

Heckler M, Michalski CW, Schaefle S, Kaiser J, Büchler MW, Hackert T.

Pancreatology. 2017 Mar - Apr;17(2):255-262. doi: 10.1016/j.pan.2017.01.011. Epub 2017 Feb 1. Review.

PMID:
28189431
18.

Current best practice and controversies in the follow up of patients with asymptomatic branch duct IPMN of the pancreas.

Tanaka M.

HPB (Oxford). 2016 Sep;18(9):709-11. doi: 10.1016/j.hpb.2016.06.014. Epub 2016 Jul 21. Review. No abstract available.

Supplemental Content

Support Center